At the news
? NEUTRALIMPACT 5/10 425 filed Sep 14, 2026 at 07:40 ET
Medtronic launched an exchange offer to split off at least 80.1% of MiniMed Group (its former Diabetes business) to MDT shareholders. Shareholders can exchange MDT shares for MMED shares at a 7% discount (~$107.53 of MMED stock per $100 of MDT stock tendered), with the offer expiring October 9, 2026. This completes the separation of MiniMed following its March 2026 IPO, allowing Medtronic to refocus capital on Cardiovascular, Neuroscience, and Surgical portfolios.
- Medtronic launched an exchange offer to split off at least 80.1% of MiniMed Group (Nasdaq: MMED) to MDT shareholders.
- Shareholders can exchange MDT ordinary shares for MMED common stock at a 7% discount, subject to an upper limit of 4.5939 MMED shares per MDT share.
- If the upper limit is not in effect, tendering shareholders are expected to receive ~$107.53 of MMED stock for every $100 of MDT stock tendered.
- Medtronic currently owns ~90% of MiniMed (252,813,348 shares) and is offering up to 225,361,295 MMED shares in the exchange.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access